OPTIMI: Early Prediction and Prevention of Depression

Institute for Response-Genetics, Departement of Psychiatry (KPPP)

Psychiatric Hospital, University of Zurich



This work was supported in part by grants of the Swiss National Science Foundation (grant numbers 32-27781.89, 32-33927.92, 32-39195.93, 32-42387.94, 32-42542.94, 32-42171.94, 32-46782.96, 32-49308.96, 32-53873.98, 32-61578.00, 31-63769.00, 32B0-103669, 32B0-103669, 32B0-119885/1).

Parts of the data were provided by the NIMH Human Genetics Initiative, with genotypes having been cleaned according to Zurich standards. The NIMH data and biomaterials were collected in three projects that participated in the National Institute of Mental Health (NIMH) Schizophrenia Genetics Initiative. From 1991-97, the Principal Investigators and Co-Investigators were: Harvard University, Boston, MA, U01 MH46318, Ming T. Tsuang, M.D., Ph.D., D.Sc., Stephen Faraone, Ph.D., and John Pepple, Ph.D.; Washington University, St. Louis, MO, U01 MH46276, C. Robert Cloninger, M.D., Theodore Reich, M.D., and Dragan Svrakic, M.D.; Columbia University, New York, NY U01 MH46289, Charles Kaufmann, M.D., Dolores Malaspina, M.D., and Jill Harkavy Friedman, Ph.D.

The normative data used in the inflammation project was gathered with the support of grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and the National Arthritis Foundation.

Chromosomal locations used in our projects rely on an integrated genetic-physical map developed in Zurich with data taken from extended versions of the deCODE, Ensembl and NCBI maps.


Prof. Dr. Hans H. Stassen

Everis, Spain
ETH, Switzerland
UZH, Switzerland
Freiburg, Germany
MA Systems, UK
Bristol, UK
Xiwrite, Italy
Ultrasis, UK
Jaume, Spain
Valencia, Spain
Lanzhou, China


EU-Grant (FP7):

[ Mail to Webmaster ] k454910@bli.uzh.ch